Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v23-FR Version v14-EN
Language French English
Date Updated 2021-02-16 2020-01-06
Drug Identification Number 02091887 02091887
Brand name RIFADIN RIFADIN
Common or Proper name Rifadin 150mg Rifadin 150mg
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients RIFAMPIN RIFAMPIN
Strength(s) 150MG 150MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100 100
ATC code J04AB J04AB
ATC description DRUGS FOR TREATMENT OF TUBERCULOSIS DRUGS FOR TREATMENT OF TUBERCULOSIS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2019-06-28 2019-06-28
Actual start date 2019-07-03 2019-07-03
Estimated end date Unknown Unknown
Actual end date 2021-01-28
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments July 15th, 2020: Rifadin strengths are in Dormant status The shortage is due to a production delay and an increase in demand. Sanofi is working diligently to make the product available as soon as possible. We are in communication with Health Canada to work towards reducing the duration of the backorder. Sanofi has no supply remaining at its warehouse or at the wholesale level. We are working diligently to make the product available as soon as possible. We are in communication with Health Canada to work towards reducing the duration of the backorder. To optimize the distribution of the product ans its availability for patients, order quantities will be limited per purchase order. Supply availability update: as of July 3, 2019 no more supply available at Sanofi warehouse.
Health Canada comments